SCHEMBL5720132

SCHEMBL5720132

Cc1cccc(C)c1CN1CCC(N2CCC(c3ccc4c(c3)[N]C(=O)N4)CC2)CC1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TRPV6 Q9H1D0 3/20 0.41
DRD2 P14416 5/20 0.41
DRD4 P21917 4/20 0.41
DRD3 P35462 2/20 0.41
CHRM1 P11229 5/20 0.41
CHRM2 P08172 1/20 0.41
CHRM4 P08173 1/20 0.41
CHRM5 P08912 1/20 0.41
CHRM3 P20309 1/20 0.41
ADRA1D P25100 1/20 0.41
HTR2C P28335 1/20 0.41
ADRA1A P35348 1/20 0.41
ADRA1B P35368 1/20 0.41
TLR9 Q9NR96 5/20 0.38
TLR7 Q9NYK1 5/20 0.38
KDM4E B2RXH2 1/20 0.37
ALDH1A1 P00352 1/20 0.37
TLR8 Q9NR97 3/20 0.36
PARP1 P09874 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5720092 0.89 CHRM1 (0.51) TRPV6DRD2DRD4DRD3CHRM1
SCHEMBL5720125 0.84 CHRM1 (0.41) TRPV6DRD2DRD4DRD3CHRM1
SCHEMBL5720279 0.84 DRD2 (0.41) TRPV6DRD2DRD4DRD3CHRM1
SCHEMBL5720269 0.84 DRD2 (0.39) TRPV6DRD2DRD4DRD3TLR9
SCHEMBL5720388 0.83 DRD2 (0.40) TRPV6DRD2DRD4DRD3TLR9
SCHEMBL5719999 0.82 CHRM2 (0.45) DRD2DRD4DRD3CHRM2CHRM3
SCHEMBL5720312 0.81 DRD2 (0.40) TRPV6DRD2DRD4DRD3CHRM1
SCHEMBL5720263 0.81 CHRM1 (0.38) TRPV6DRD2DRD4DRD3CHRM1
SCHEMBL5720385 0.79 CHRM1 (0.53) TRPV6DRD2CHRM1KDM4EALDH1A1
SCHEMBL5720128 0.79 TLR7 (0.44) TRPV6DRD2DRD4DRD3TLR9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1515722-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2006-06-21 EP claimed
EP-1515722-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2005-03-23 EP claimed
WO-2003105781-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2003-12-24 WO claimed
EP-1515722-A4 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO INC (US) 2006-06-21 EP disclosed
EP-1515722-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION Merck & Co., Inc. (US) 2005-03-23 EP disclosed
WO-2003105781-A2 OPHTHALMIC COMPOSITIONS FOR TREATING OCULAR HYPERTENSION MERCK & CO., INC. (US) 2003-12-24 WO disclosed